A dynamic invoice generation system built with Node.js and Express. It uses EJS templating for rendering invoice data from JSON and Puppeteer to generate downloadable PDF invoices.

Add payment QR codes with any invoice-related information (payment links, UPI, contact details, custom data) and seamless multi-page support with automatic pagination and page breaks for large ...

A newly disclosed security issue in the popular jsPDF library has raised serious concerns for web developers. The flaw could ...

It's a lifesaver.

We list the best billing and invoicing software, to make it simple and easy to manage your income and expenses. Even better, many options cost little to use, or are even free for light use. Free ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate is indicative of a more mature startup that may have a better chance of succeeding in today’s markets. Industry IPOs peaked in 2021, resulting in a flood of companies whose early science didn ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...